Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gospodarowicz

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|September 2, 1999
The role of cancer staging in evidence-based medicineW J Mackillop, B O'Sullivan, M Gospodarowicz
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|September 2, 1999
Cancer stagingB O'Sullivan, M Gospodarowicz, W J Mackillop
Seminars in Oncology|June 22, 1999
Primary non-Hodgkin's lymphoma of boneJ Baar, R L Burkes, M Gospodarowicz
Seminars in Oncology|June 22, 1999
Lymphoma of the gastrointestinal tractM Crump, M Gospodarowicz, F A Shepherd
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 9, 2016
Radiotherapy in Low- and Middle-income Countries. What Can We Do Differently?M B Barton, E Zubizarreta, M Gospodarowicz
Cancer|January 15, 1983
Chemotherapy for metastatic transitional carcinoma of the urinary tract. A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failureI F Tannock, M Gospodarowicz, W K Evans
Urologic Oncology|June 22, 2001
Surveillance for stage I testicular seminoma. a reviewA Bayley, P Warde, M Milosevic, et al.
Hematological Oncology|January 1, 1984
Mediastinal involvement by Hodgkin's disease and the implications for management for those patients with local or loco-regional diseaseS B Sutcliffe, M Gospodarowicz, R S Bush
The Journal of Urology|August 1, 1989
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experienceI Tannock, M Gospodarowicz, J Connolly, et al.
The Canadian Journal of Oncology|July 1, 1995
Focus group methodology in the development of a survey to measure physician use of cancer staging systemsF D Ashbury, M Gospodarowicz, E Kaegi, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|September 2, 1999
The role of cancer staging in evidence-based medicineW J Mackillop, B O'Sullivan, M Gospodarowicz
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC|September 2, 1999
Cancer stagingB O'Sullivan, M Gospodarowicz, W J Mackillop
Seminars in Oncology|June 22, 1999
Primary non-Hodgkin's lymphoma of boneJ Baar, R L Burkes, M Gospodarowicz
Seminars in Oncology|June 22, 1999
Lymphoma of the gastrointestinal tractM Crump, M Gospodarowicz, F A Shepherd
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 9, 2016
Radiotherapy in Low- and Middle-income Countries. What Can We Do Differently?M B Barton, E Zubizarreta, M Gospodarowicz
Cancer|January 15, 1983
Chemotherapy for metastatic transitional carcinoma of the urinary tract. A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failureI F Tannock, M Gospodarowicz, W K Evans
Urologic Oncology|June 22, 2001
Surveillance for stage I testicular seminoma. a reviewA Bayley, P Warde, M Milosevic, et al.
Hematological Oncology|January 1, 1984
Mediastinal involvement by Hodgkin's disease and the implications for management for those patients with local or loco-regional diseaseS B Sutcliffe, M Gospodarowicz, R S Bush
The Journal of Urology|August 1, 1989
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experienceI Tannock, M Gospodarowicz, J Connolly, et al.
The Canadian Journal of Oncology|July 1, 1995
Focus group methodology in the development of a survey to measure physician use of cancer staging systemsF D Ashbury, M Gospodarowicz, E Kaegi, et al.
Pageof 6